The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. NovoRapid was produced by Novo Nordisk.
Ryzodeg contains a combination of long acting insulin degludec – which Novo markets as Tresiba – and rapid-acting insulin aspart, while Novo sells as NovoRapid. ... The assumption from Novo’s announcement is that Tresibo and NovoRapid, as well as
The mylife YpsoPump is fitted with a touch screen, reducing the need for training, and is fully compatible with Novo Nordisk's prefilled pump cartridge, NovoRapid PumpCart, which negates the need ... NovoRapid was awarded a European license in 1999 and
After Seretide, another respiratory drug from AstraZeneca - Symbicort - saw the second highest spend with £89m, while Novo Nordisk's insulin NovoRapid came in third with the NHS spending £75m on the
Novo has built its business on a range of diabetes, led by currently the insulins Levemir, NovoRapid and Tresiba and the GLP-1 agonist Victoza (liraglutide).
These include Tresiba-based combination therapy IDegLira, which incorporates insulin degludec plus liraglutide (the API in GLP-1 agonist Victoza), a revamped version of fast-acting insulin product NovoLog/NovoRapid (insulin
No results were found
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...